Current Vascular Pharmacology
Title:Meet Our Regional Editor
Volume: 16 Issue: 4
Author(s): Greg J. Dusting
Affiliation:
Export Options
About this article
Cite this article as:
Dusting J. Greg , Meet Our Regional Editor, Current Vascular Pharmacology 2018; 16 (4) . https://dx.doi.org/10.2174/157016111604180517091313
DOI https://dx.doi.org/10.2174/157016111604180517091313 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cholinergic Treatment of Traumatic Brain Injury
Current Drug Therapy Pregnancy, Programming and Preeclampsia: Gap Junctions at the Nexus of Pregnancy-induced Adaptation of Endothelial Function and Endothelial Adaptive Failure in PE
Current Vascular Pharmacology Clinical Vignettes: Integrated Care of Cancer Patients by Oncologists and Cardiologists
Current Cardiology Reviews Peptide-Derived Protease-Activated Receptor-1 (PAR-1) Antagonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Standardization of QRS Duration Measurement and LBBB Criteria in CRT Trials and Clinical Practice
Current Cardiology Reviews Mediterranean Diet in Predementia and Dementia Syndromes
Current Alzheimer Research Advances on PPARγ Research in the Emerging Era of Precision Medicine
Current Drug Targets Evaluation of Cardiac Scan in Diagnosing Coronary-artery Disease
Current Medical Imaging Current Clinical Applications of Botulinum Toxin
Current Pharmaceutical Design Peroxynitrite-Driven Mechanisms in Diabetes and Insulin Resistance – the Latest Advances
Current Medicinal Chemistry Emerging Use of Nanotechnology in the Treatment of Neurological Disorders
Current Pharmaceutical Design The Hellp Syndrome: A Review
Current Women`s Health Reviews Polypoidal Choroidal Vasculopathy: Recent Advances in Therapy
Current Drug Targets Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease
Current Pharmaceutical Design Hypoxia Inducible Factor-1 as a Therapeutic Target in Cerebral Ischemia
Current Signal Transduction Therapy Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry The Risks and Benefits of Therapy with Aldosterone Receptor Antagonist Therapy
Current Drug Safety Adult Neurogenesis in the Hypothalamus: Evidence, Functions and Implications
CNS & Neurological Disorders - Drug Targets A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase
Current Medicinal Chemistry Meet Our Editorial Board Member
Current Biomarkers (Discontinued)